Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Tvardi Therapeutics Inc
F:69C
Tvardi Therapeutics Inc
F:69C
Price:
1
EUR
2.04%
Market Closed
Market Cap:
€54.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tvardi Therapeutics Inc
F:69C
|
US |
|
H
|
Hyflux Ltd
F:HYF
|
SG |
|
N
|
Newmont Corporation
DUS:NMM
|
US |
|
Fraport AG Frankfurt Airport Services Worldwide
OTC:FPRUF
|
DE |
|
IP Group PLC
F:IOOA
|
UK |
|
Compagnie des Alpes SA
F:JCA
|
FR |
|
Aedifica NV
OTC:AEDFF
|
BE |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 69C's stock price target?
Price Target
8.23
EUR
8.23
EUR
According to Wall Street analysts, the average 1-year price target for 
69C is 8.23 EUR with a low forecast of 2.44 EUR and a high forecast of 11.85 EUR.
What is the Revenue forecast for Tvardi Therapeutics Inc?
Projected CAGR
38%
38%
Over the last 12 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 9 years is 38%.
What is the Gross Profit forecast for Tvardi Therapeutics Inc?
Projected CAGR
39%
39%
The compound annual growth rate for Gross Profit over the next 9 years is 39%.